| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $695,612 ) |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 14 | 6/21/2024 | NON-COMPETING CONTINUATION | $695,612 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $724,596 ) |
| 2023 | 2023 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 13 | 8/3/2023 | NON-COMPETING CONTINUATION | $724,596 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $724,596 ) |
| 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 12 | 6/6/2022 | NON-COMPETING CONTINUATION | $724,596 |
| 2022 | 2020 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 10 | 11/12/2021 | NON-COMPETING CONTINUATION | $0 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $742,846 ) |
| 2021 | 2021 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 11 | 6/10/2021 | COMPETING CONTINUATION | $742,846 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2020 ( Subtotal = $604,095 ) |
| 2020 | 2020 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 10 | 5/12/2020 | NON-COMPETING CONTINUATION | $604,095 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2019 ( Subtotal = $604,095 ) |
| 2019 | 2019 | VANDERBILT UNIVERSITY, THE | 2301 VANDERBILT PL | NASHVILLE | TN | 37235 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 9 | 5/22/2019 | NON-COMPETING CONTINUATION | $604,095 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2018 ( Subtotal = $604,095 ) |
| 2018 | 2018 | VANDERBILT UNIVERSITY, THE | 2301 VANDERBILT PL | NASHVILLE | TN | 37235 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 8 | 6/7/2018 | NON-COMPETING CONTINUATION | $604,095 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2017 ( Subtotal = $606,184 ) |
| 2017 | 2017 | VANDERBILT UNIVERSITY, THE | 211 KIRKLAND HALL | NASHVILLE | TN | 37240 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 003 | 7 | 7/4/2017 | NON-COMPETING CONTINUATION | $604,095 |
| 2017 | 2016 | VANDERBILT UNIVERSITY, THE | 211 KIRKLAND HALL | NASHVILLE | TN | 37240 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 6 | 1/5/2017 | COMPETING CONTINUATION | $41,192 |
| 2017 | 2016 | VANDERBILT UNIVERSITY, THE | 211 KIRKLAND HALL | NASHVILLE | TN | 37240 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 6 | 12/8/2016 | COMPETING CONTINUATION | $2,089 |
| 2017 | 2015 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 002 | 5 | 1/5/2017 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | -$41,192 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2016 ( Subtotal = $631,325 ) |
| 2016 | 2016 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 003 | 6 | 9/21/2016 | COMPETING CONTINUATION | $627,666 |
| 2016 | 2015 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 5/19/2016 | NON-COMPETING CONTINUATION | -$222,463 |
| 2016 | 2015 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 002 | 4 | 5/30/2016 | NON-COMPETING CONTINUATION | -$102,462 |
| 2016 | 2015 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 5 | 5/19/2016 | CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION | $328,584 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2015 ( Subtotal = $551,081 ) |
| 2015 | 2015 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 9/4/2015 | NON-COMPETING CONTINUATION | $551,081 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2014 ( Subtotal = $550,542 ) |
| 2014 | 2014 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 8/1/2014 | NON-COMPETING CONTINUATION | $550,542 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2013 ( Subtotal = $537,922 ) |
| 2013 | 2013 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 8/27/2013 | NON-COMPETING CONTINUATION | $537,922 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2012 ( Subtotal = $541,281 ) |
| 2012 | 2012 | VANDERBILT UNIVERSITY HOSPITAL, CHILDREN'S REHAB UNIT | 1161 21ST AVENUE SOUTH | NASHVILLE | TN | 37232 | DAVIDSON | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 9/11/2012 | NEW | $541,281 |
|
|